Yohei Funakoshi

1.9k total citations · 1 hit paper
66 papers, 1.4k citations indexed

About

Yohei Funakoshi is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yohei Funakoshi has authored 66 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 16 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yohei Funakoshi's work include SARS-CoV-2 and COVID-19 Research (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer Cells and Metastasis (7 papers). Yohei Funakoshi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cancer Cells and Metastasis (7 papers). Yohei Funakoshi collaborates with scholars based in Japan, United States and Switzerland. Yohei Funakoshi's co-authors include Hironobu Minami, Naomi Kiyota, Toru Mukohara, Masanori Toyoda, Yoshinori Imamura, Yohei Shimono, Naoko Chayahara, Shintaro Takao, Seishi Kono and Tetsuya Nakatsura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yohei Funakoshi

59 papers receiving 1.3k citations

Hit Papers

Comparison of 2D- and 3D-culture models as drug-testing p... 2015 2026 2018 2022 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
    2015 639 citations Yoshinori Imamura, Toru Mukohara et al. Oncology Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohei Funakoshi Japan 15 543 440 397 188 172 66 1.4k
Naoko Chayahara Japan 18 577 1.1× 356 0.8× 381 1.0× 172 0.9× 252 1.5× 44 1.4k
Masanori Toyoda Japan 17 592 1.1× 373 0.8× 395 1.0× 423 2.3× 301 1.8× 71 1.6k
Amanda M. Clark United States 20 558 1.0× 468 1.1× 374 0.9× 191 1.0× 107 0.6× 38 1.3k
Nina M. Muñoz United States 19 416 0.8× 660 1.5× 254 0.6× 111 0.6× 129 0.8× 29 1.3k
Ai Sato Japan 16 592 1.1× 630 1.4× 183 0.5× 162 0.9× 145 0.8× 45 1.4k
Magdalena Winiarska Poland 20 390 0.7× 432 1.0× 199 0.5× 100 0.5× 240 1.4× 63 1.4k
Gilles Renault France 21 299 0.6× 425 1.0× 326 0.8× 102 0.5× 79 0.5× 53 1.3k
Shujie Zhao United States 14 570 1.0× 755 1.7× 166 0.4× 133 0.7× 172 1.0× 17 1.5k

Countries citing papers authored by Yohei Funakoshi

Since Specialization
Citations

This map shows the geographic impact of Yohei Funakoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Funakoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Funakoshi more than expected).

Fields of papers citing papers by Yohei Funakoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Funakoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Funakoshi. The network helps show where Yohei Funakoshi may publish in the future.

Co-authorship network of co-authors of Yohei Funakoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Funakoshi. A scholar is included among the top collaborators of Yohei Funakoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Funakoshi. Yohei Funakoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohji, Goh, Yohei Funakoshi, Kimikazu Yakushijin, et al.. (2024). Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d). Frontiers in Immunology. 15. 1468760–1468760.
2.
Nagatani, Yoshiaki, Naomi Kiyota, Yu Imamura, et al.. (2024). 426P Trop-2 and Nectin-4 expression and their relationship with tumor immune microenvironment in salivary gland cancer. Annals of Oncology. 35. S1562–S1563.
3.
4.
Saito, Yasuyuki, Alaa Refaat, Daisuke Hazama, et al.. (2023). Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models. Frontiers in Immunology. 14. 1294814–1294814. 4 indexed citations
5.
Tanaka, Yugo, Takefumi Doi, Hironori Sakai, et al.. (2023). Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy. Surgery Today. 53(9). 1057–1063.
6.
Funakoshi, Yohei, Kimikazu Yakushijin, Goh Ohji, et al.. (2022). Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination. Vaccines. 10(6). 965–965. 3 indexed citations
7.
Imamura, Yoshinori, Kazunori Otsui, Kenta Mori, et al.. (2022). Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial. International Journal of Hematology. 115(4). 499–507. 4 indexed citations
8.
Nakajima, Takeo, Tatsuya Nagano, Shoko Murakami, et al.. (2022). Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients. Allergy Asthma and Clinical Immunology. 18(1). 78–78. 3 indexed citations
9.
Funakoshi, Yohei, Kimikazu Yakushijin, Goh Ohji, et al.. (2021). Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer. Journal of Infection and Chemotherapy. 28(4). 516–520. 12 indexed citations
10.
Funakoshi, Yohei, Goh Ohji, Kimikazu Yakushijin, et al.. (2021). Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19. Heliyon. 7(8). e07748–e07748. 4 indexed citations
11.
Imamura, Yoshinori, Shinya Ohata, Yohei Funakoshi, et al.. (2021). Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients. International Journal of Hematology. 114(3). 319–324. 2 indexed citations
12.
Nagatani, Yoshiaki, Yohei Funakoshi, Yoshinori Imamura, et al.. (2021). Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells. Journal of Cancer Research and Therapeutics. 17(4). 1093–1100. 7 indexed citations
13.
Suzuki, Chiaki, Naomi Kiyota, Yoshinori Imamura, et al.. (2020). Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer. International Journal of Clinical Oncology. 25(7). 1270–1277. 14 indexed citations
14.
Funakoshi, Yohei, Ying Wang, Takashi Semba, et al.. (2019). Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype. PLoS ONE. 14(9). e0222336–e0222336. 17 indexed citations
15.
Funakoshi, Yohei, Yutaka Fujiwara, Naomi Kiyota, et al.. (2016). Validity of new methods to evaluate renal function in cancer patients treated with cisplatin. Cancer Chemotherapy and Pharmacology. 77(2). 281–288. 21 indexed citations
16.
Imamura, Yoshinori, Toru Mukohara, Yohei Shimono, et al.. (2015). Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncology Reports. 33(4). 1837–1843. 639 indexed citations breakdown →
17.
Kataoka, Tomoko, et al.. (2015). Oral supportive care for cancer patients receiving chemotherapy. Annals of Oncology. 26. vii117–vii117.
18.
Funakoshi, Yohei, Yutaka Fujiwara, Naomi Kiyota, et al.. (2013). Prediction of Glomerular Filtration Rate in Cancer Patients by an Equation for Japanese Estimated Glomerular Filtration Rate. Japanese Journal of Clinical Oncology. 43(3). 271–277. 18 indexed citations
19.
Mukohara, Toru, Yu Kataoka, Yohei Funakoshi, et al.. (2012). Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line. Investigational New Drugs. 31(2). 293–303. 18 indexed citations
20.
Funakoshi, Yohei, et al.. (2007). In vitro development of gut‐like tissue demonstrating rhythmic contractions from embryonic mouse intestinal cells. Neurogastroenterology & Motility. 19(4). 288–300. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoko Chayahara Breakdown of academic impact, for papers by Masanori Toyoda Breakdown of academic impact, for papers by Amanda M. Clark Breakdown of academic impact, for papers by Nina M. Muñoz Breakdown of academic impact, for papers by Ai Sato Breakdown of academic impact, for papers by Magdalena Winiarska Breakdown of academic impact, for papers by Gilles Renault Breakdown of academic impact, for papers by Shujie Zhao
Rankless by CCL
2026